Acorn Financial Advisory Services Inc Collegium Pharmaceutical, Inc Transaction History
Acorn Financial Advisory Services Inc
- $508 Million
- Q3 2024
A detailed history of Acorn Financial Advisory Services Inc transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Acorn Financial Advisory Services Inc holds 30,109 shares of COLL stock, worth $978,843. This represents 0.23% of its overall portfolio holdings.
Number of Shares
30,109
Previous 30,942
2.69%
Holding current value
$978,843
Previous $996,000
16.77%
% of portfolio
0.23%
Previous 0.21%
Shares
20 transactions
Others Institutions Holding COLL
# of Institutions
247Shares Held
37.6MCall Options Held
100KPut Options Held
21.1K-
Black Rock Inc. New York, NY5.79MShares$188 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$85.7 Million1.79% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.35MShares$76.3 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.14MShares$69.7 Million0.15% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.66MShares$53.8 Million0.1% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.11B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...